Modulation of gut microbiome composition and function in experimental colitis treated with sulfasalazine

Frontiers in Microbiology

Volumn 8, Issue SEP, 2017, Pages

  Zheng, Haihui ^a   Chen, Mingyi ^a   Li, Yuan ^b   Wang, Yuanyuan ^c   Wei, Lin ^a   Liao, Ziqiong ^a   Wang, Mengxia ^b   Ma, Fangli ^c   Liao, Qiongfeng ^b   Xie, Zhiyong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^c Infinitus (China) Company Ltd   (China)

Author keywords

16S gene sequencing; Colitis; Gut microbiome; Metagenomics; SASP; TNBS

Indexed keywords

MYELOPEROXIDASE; RNA 16S; SALAZOSULFAPYRIDINE;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEROIDETES; BIOINFORMATICS; CARBOHYDRATE METABOLISM; CELL MOTILITY; CHEMOTAXIS; CONTROLLED STUDY; DISEASE ACTIVITY; DNA EXTRACTION; DYSBIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FIRMICUTES; GENE SEQUENCE; GENETIC ANALYSIS; HISTOPATHOLOGY; INFERTILITY; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY INFILTRATE; INTESTINE FLORA; MALE; METAGENOME; MOLLICUTES; MUCOSA INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PHYLOGENY; PROTEOBACTERIA; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA GENE; TRINITROBENZENE SULFONIC ACID-INDUCED COLITIS;

EID: 85028981906     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.01703     Document Type: Article

References (68)

1. Ahmad, M. S., Krishnan, S., Ramakrishna, B. S., Mathan, M., Pulimood, A. B., and Murthy, S. N. (2000). Butyrate and glucose metabolism by colonocytes in experimental colitis in mice. Gut 46, 493-499. doi: 10.1136/gut.46. 4.493
2. Alex, P., Zachos, N. C., Nguyen, T., Gonzales, L., Chen, T. E., Conklin, L. S., et al. (2009). Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm. Bowel. Dis. 15, 341-352. doi: 10.1002/ibd.20753
3. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990). Basic local alignment search tool. J. Mol. Biol. 215, 403-410. doi: 10.1016/S0022-2836(05)80360-2
4. Azad Khan, A. K., Piris, J., and Truelove, S. C. (1977). An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 2, 892-895. doi: 10.1016/S0140-6736(77)90831-5
5. Backhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., et al. (2015). Dynamics and stabilization of the human gut microbiome during the first year of life. Cell HostMicrobe 17, 690-703. doi: 10.1016/j.chom.2015.04.004
6. Balish, E., and Warner, T. (2002). Enterococcus faecalis can induce inflammatory bowel disease in interleukin-10 knockout mice. Am. J. Pathol. 160, 2253-2257. doi: 10.1016/S0002-9440(10)61172-8
7. Bokulich, N. A., Subramanian, S., Faith, J. J., Gevers, D., Gordon, J. I., Knight, R., et al. (2013). Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nat. Methods 10, 57-59. doi: 10.1038/nmeth. 2276
8. Cadwell, K., Patel, K. K., Maloney, N. S., Liu, T. C., Ng, A. C., Storer, C. E., et al. (2010). Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141, 1135-1145. doi: 10.1016/j.cell. 2010.05.009
9. Chassard, C., and Bernalier-Donadille, A. (2006). H2 and acetate transfers during xylan fermentation between a butyrate-producing xylanolytic species and hydrogenotrophic microorganisms from the human gut. FEMS Microbiol. Lett. 254, 116-122. doi: 10.1111/j.1574-6968.2005.00016.x
10. Chatzinoff, M., Guarino, J. M., Corson, S. L., Batzer, F. R., and Friedman, L. S. (1988). Sulfasalazine-induced abnormal sperm penetration assay reversed on changing to 5-aminosalicylic acid enemas. Dig. Dis. Sci. 33, 108-110. doi: 10.1007/BF01536639
11. Cooke, E. M. (1968). Properties of strains of Escherichia coli isolated from the faeces of patients with ulcerative colitis, patients with acute diarrhoea and normal persons. J. Pathol. Bacteriol. 95, 101-113. doi: 10.1002/path.1700950112
12. Cooke, E. M. (1969). Faecal flora of patients with ulcerative colitis during treatment with salicylazosulphapyridine. Gut 10, 565-568. doi: 10.1136/gut.10.7.565
13. Cooper, H. S., Murthy, S. N., Shah, R. S., and Sedergran, D. J. (1993). Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69, 238-249.
14. Cuzon, G., Naas, T., Fortineau, N., and Nordmann, P. (2008). Novel chromogenic medium for detection of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis. J. Clin. Microbiol. 46, 2442-2444. doi: 10.1128/JCM. 00492-08
15. DeSantis, T. Z. Jr., Hugenholtz, P., Keller, K., Brodie, E. L., Larsen, N., Piceno, Y. M., et al. (2006a). NAST: a multiple sequence alignment server for comparative analysis of 16S rRNA genes. Nucleic Acids Res. 34, W394-W399. doi: 10.1093/nar/gkl244
16. DeSantis, T. Z. Jr., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., et al. (2006b). Greengenes, a chimera checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72, 5069-5072. doi: 10.1128/AEM.03006-05
17. Dethlefsen, L., Huse, S., Sogin, M. L., and Relman, D. A. (2008). The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS. Biol. 6:e280. doi: 10.1371/journal.pbio.0060280
18. Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., et al. (2005). Diversity of the human intestinal microbial flora. Science 308, 1635-1638. doi: 10.1126/science.1110591
19. Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., and Knight, R. (2011). UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194-2200. doi: 10.1093/bioinformatics/btr381
20. Engel, M. A., and Neurath, M. F. (2010). New pathophysiological insights and modern treatment of IBD. J. Gastroenterol. 45, 571-583. doi: 10.1007/s00535-010-0219-3
21. Flint, H. J., Bayer, E. A., Rincon, M. T., Lamed, R., and White, B. A. (2008). Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat. Rev. Microbiol. 6, 121-131. doi: 10.1038/nrmicro1817
22. Furrie, E., Macfarlane, S., Kennedy, A., Cummings, J. H., Walsh, S. V., O'neil, D. A., et al. (2005). Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54, 242-249.
23. Gaudio, E., Taddei, G., Vetuschi, A., Sferra, R., Frieri, G., Ricciardi, G., et al. (1999). Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects. Dig. Dis. Sci. 44, 1458-1475. doi: 10.1023/A: 1026620322859
24. Gorbach, S. L., Nahas, L., Plaut, A. G., Weinstein, L., Patterson, J. F., and Levitan, R. (1968). Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy. Gastroenterology 54, 575-587.
25. Hazenbe, M. P., Bakker, M., Both-Patoir, H. C., Ruseler-van Embden, J. G., and Schröder, A. M. (1982). Effect of sulphasalazineon the human intestinal flora. J. Appl. Bacteriol. 52, 103-107. doi: 10.1111/j.1365-2672.1982. tb04379.x
26. He, Q., Li, X., Liu, C., Su, L., Xia, Z., Li, X., et al. (2016). Dysbiosis of the fecal microbiota in the TNBS-induced Crohn's disease mouse model. Appl. Microbiol. Biotechnol. 100, 4485-4494. doi: 10.1007/s00253-015-7205-x
27. Higa, A., Eto, T., and Nawa, Y. (1997). Evaluation of the role of neutrophils in the pathogenesis of acetic acid-induced colitis in mice. Scand. J. Gastroenterol. 32, 564-568. doi: 10.3109/00365529709025100
28. Jamalizadeh Bahaabadi, S., Mohseni Moghadam, N., Kheirkhah, B., Farsinejad, A., and Habibzadeh, V. (2014). Isolation and molecular identification of Mycoplasma hominis in infertile female and male reproductive system. Nephrourol. Mon. 6:e22390. doi: 10.5812/numonthly.22390
29. Kanehisa, M., Araki, M., Goto, S., Hattori, M., Hirakawa, M., Itoh, M., et al. (2008). KEGG for linking genomes to life and the environment. Nucleic Acids Res. 36, D480-D484. doi: 10.1093/nar/gkm882
30. Kang, S., Denman, S. E., Morrison, M., Yu, Z., Dore, J., Leclerc, M., et al. (2010). Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray. Inflamm. Bowel. Dis. 16, 2034-2042. doi: 10.1002/ibd. 21319
31. Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., and Fagerberg, B. (2013). Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99-103. doi: 10.1038/nature12198
32. Kostic, A. D., Xavier, R. J., and Gevers, D. (2014). The microbiome in inflammatory bowel diseases: current status and the future ahead. Gastroenterology 146, 1489-1499. doi: 10.1053/j.gastro.2014.02.009
33. Langille, M. G., Zaneveld, J., Caporaso, J. G., McDonald, D., Knights, D., Reyes, J. A., et al. (2013). Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 31, 814-821. doi: 10.1038/nbt.2676
34. Li, H., and Durbin, R. (2010). Fast and accurate long-read alignment with Burrows- Wheeler transform. Bioinformatics 26, 589-595. doi: 10.1093/bioinformatics/btp698
35. Li, J., Jia, H., Cai, X., Zhong, H., Feng, Q., Sunagawa, S., et al. (2014). An integrated catalog of reference genes in the human gut microbiome. Nat. Biotechnol. 32, 834-841. doi: 10.1038/nbt.2942
36. Li, W., and Godzik, A. (2006). Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 22, 1658-1659. doi: 10.1093/bioinformatics/btl158
37. Ling, Z., Liu, X., Jia, X., Cheng, Y., Luo, Y., Yuan, L., et al. (2014). Impacts of infection with different toxigenic Clostridium difficile strains on faecal microbiota in children. Sci. Rep. 4:7485. doi: 10.1038/srep07485
38. Lodes, M. J., Cong, Y., Elson, C. O., Mohamath, R., Landers, C. J., Targan, S. R., et al. (2004). Bacterial flagellin is a dominant antigen in Crohn disease. J. Clin. Invest. 113, 1296-1306.
39. Luo, R., Liu, B., Xie, Y., Li, Z., Huang, W., Yuan, J., et al. (2012). SOAPdenovo2: an empirically improved memory-efficient short-read de novo assembler. Gigascience 1:18. doi: 10.1186/2047-217X-1-18
40. Magoč, T., and Salzberg, S. L. (2011). FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27, 2957-2963. doi: 10.1093/bioinformatics/btr507
41. Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., et al. (2006). Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55, 205-211. doi: 10.1136/gut.2005.073817
42. Martinez, C., Antolin, M., Santos, J., Torrejon, A., Casellas, F., Borruel, N., et al. (2008). Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission. Am. J. Gastroenterol. 103, 643-648. doi: 10.1111/j.1572-0241. 2007.01592.x
43. Mizoguchi, A. (2012). Animal models of inflammatory bowel disease. Prog. Mol. Biol. Transl. Sci. 105, 263-320. doi: 10.1016/B978-0-12-394596-9.00009-3
44. Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., et al. (2012). Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome. Biol. 13:R79. doi: 10.1186/gb-2012-13-9-r79
45. Morris, G. P., Beck, P. L., Herridge, M. S., Depew, W. T., Szewczuk, M. R., and Wallace, J. L. (1989). Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96, 795-803.
46. Murthy, S. N., Cooper, H. S., Shim, H., Shah, R. S., Ibrahim, S. A., and Sedergran, D. J. (1993). Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig. Dis. Sci. 38, 1722-1734. doi: 10.1007/BF01303184
47. Navas-Molina, J. A., Peralta-Sánchez, J. M., González, A., McMurdie, P. J., Vázquez-Baeza, Y., Xu, Z., et al. (2013). Advancing our understanding of the human microbiome using QIIME. Methods Enzymol. 531, 371-444. doi: 10.1016/B978-0-12-407863-5.00019-8
48. Ott, S. J., Musfeldt, M., Wenderoth, D. F., Hampe, J., Brant, O., Fölsch, U. R., et al. (2004). Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53, 685-693. doi: 10.1136/gut.2003.025403
49. Parks, D. H., Tyson, G. W., Hugenholtz, P., and Beiko, R. G. (2014). STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics 30, 3123-3124. doi: 10.1093/bioinformatics/btu494
50. Peloquin, J. M., andNguyen, D. D. (2013). The microbiota and inflammatory bowel disease: insights from animal models. Anaerobe 24, 102-106. doi: 10.1016/j. anaerobe.2013.04.006
51. Peppercorn, M. A. (1984). Sulfasalazine: pharmacology, clinical use, toxicity, and related new drug development. Ann. Intern. Med. 101, 377-386. doi: 10.7326/0003-4819-101-3-377
52. Pineton de Chambrun, G. P., and Sandborn, W. J. (2012). IBD in 2011: advances in IBD managemen-towards a tailored approach. Nat. Rev. Gastroenterol. Hepatol. 9, 70-72. doi: 10.1038/nrgastro.2011.248
53. Presley, L. L., Ye, J., Li, X., Leblanc, J., Zhang, Z., Ruegger, P. M., et al. (2012). Hostmicrobe relationships in inflammatory bowel disease detected by bacterial and metaproteomic analysis of the mucosal-luminal interface. Inflamm. Bowel. Dis. 18, 409-417. doi: 10.1002/ibd.21793
54. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., et al. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65. doi: 10.1038/nature08821
55. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., et al. (2012). A metagenomewide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60. doi: 10.1038/nature11450
56. Qin, N., Yang, F., Li, A., Prifti, E., Chen, Y., Shao, L., et al. (2014). Alterations of the human gut microbiome in liver cirrhosis. Nature 513, 59-64. doi: 10.1038/nature13568
57. Roberfroid, M., Gibson, G. R., Hoyles, L., McCartney, A. L., Rastall, R., Rowland, I., et al. (2010). Prebiotic effects: metabolic and health benefits. Br. J. Nutr. 104(Suppl. 2), S1-S63. doi: 10.1017/S000711451000 3363
58. Rooks, M. G., Veiga, P., Wardwell-Scott, L. H., Tickle, T., Segata, N., Michaud, M., et al. (2014). Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. ISME J. 8, 1403-1417. doi: 10.1038/ismej.2014.3
59. Rubin, N. H., and Baur, P. S. (1983). A sample-grouping technique for paraffin embedments. Stain Technol. 58, 157-160.
60. Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., et al. (2011). Metagenomic biomarker discovery and explanation. Genome Biol. 12:R60. doi: 10.1186/gb-2011-12-6-r60
61. Sherrill, C., and Fahey, R. C. (1998). Import and metabolism of glutathione by Streptococcus mutans. J. Bacteriol. 180, 1454-1459.
62. Sokol, H., and Seksik, P. (2010). The intestinal microbiota in inflammatory bowel diseases: time to connect with the host. Curr. Opin. Gastroenterol. 26, 327-333. doi: 10.1097/MOG.0b013e328339536b
63. Taffet, S. L., and Das, K. M. (1983). Sulfasalazine. Adverse effects and desensitization. Dig. Dis. Sci. 28, 833-842. doi: 10.1007/BF01296907
64. Toovey, S., Hudson, E., Hendry, W. F., and Levi, A. J. (1981). Suiphasalazine and male infertility: reversibility and possible mechanism. Gut 22, 445-451. doi: 10.1136/gut.22.6.445
65. Veerappan, G. R., Betteridge, J., and Young, P. E. (2012). Probiotics for the treatment of inflammatory bowel disease. Curr. Gastroenterol. Rep. 14, 324-333. doi: 10.1007/s11894-012-0265-5
66. Wang, W., Chen, L., Zhou, R., Wang, X., Song, L., Huang, S., et al. (2014). Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory Bowel disease. J. Clin. Microbiol. 52, 398-406. doi: 10.1128/JCM.01500-13
67. West, B., Lendrum, R., Hill, M. J., and Walker, G. (1974). Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease. Gut 15, 960-965. doi: 10.1136/gut.15.12.960
68. Zoetendal, E. G., Rajilic-Stojanovic, M., and de Vos, W. M. (2008). Highthroughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57, 1605-1615. doi: 10.1136/gut.2007.133603